A gene is considered a candidate gene for type 2 diabetes in Pima Indians if 1) it has a known physiological function in a pathway relevant to type 2 diabetes/obesity or 2) it is associated with diabetes/obesity in another human population or in an animal model. Candidate genes analyzed in the past year include: PPARg2, PGC-1, IRS-1, IRS-2, FOXC2, and MCR4. Poymorphisms were identified in all of these genes and analyzed for association. As an example, the melanocortin 4 receptor (MC4R), has been identified as the cause of rare forms of monogenic obesity in both humans and rodents. Heterozygous coding mutations in MCR4 are implicated in 1 to 6% of early onset or severe adult obesity. As part of our efforts to identify obesity susceptibility loci in the Pima Indians, we screened MCR4 as a candidate gene. Sequencing of MCR4 in 96 severely obese Pima subjects identified two rare coding region variants and one common promoter variant. One coding variant predicts an arginine to lysine substitution at codon 165 (R165Q), while the second coding variant is a single base insertion (A) which predicts a premature STOP (TGA) at codon 37. The R165Q has been previously identified in other populations, and functional studies have shown that it dramatically reduces the activity of MCR4. In contrast, the single base insertion at nucleotide 100 has not yet been reported. Genotyping of the common promoter variant in a large cohort of Pima Indians indicates that this variant is highly associated with obesity in the general Pima population. We are currently pursuing functional studies on this gene.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK069071-07
Application #
6810606
Study Section
(PECR)
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2003
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Traurig, Michael; Mack, Janel; Hanson, Robert L et al. (2009) Common variation in SIM1 is reproducibly associated with BMI in Pima Indians. Diabetes 58:1682-9
Rong, Rong; Hanson, Robert L; Ortiz, Daniel et al. (2009) Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes 58:478-88
Traurig, M; Hanson, R L; Kobes, S et al. (2007) Protein tyrosine phosphatase 1B is not a major susceptibility gene for type 2 diabetes mellitus or obesity among Pima Indians. Diabetologia 50:985-9
Guo, Tingwei; Hanson, Robert L; Traurig, Michael et al. (2007) TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3,501 individuals. Diabetes 56:3082-8
Korner, A; Ma, L; Franks, P W et al. (2007) Sex-specific effect of the Val1483Ile polymorphism in the fatty acid synthase gene (FAS) on body mass index and lipid profile in Caucasian children. Int J Obes (Lond) 31:353-8
Traurig, Michael T; Permana, Paska A; Nair, Saraswathy et al. (2006) Differential expression of matrix metalloproteinase 3 (MMP3) in preadipocytes/stromal vascular cells from nonobese nondiabetic versus obese nondiabetic Pima Indians. Diabetes 55:3160-5
Guo, Yan; Traurig, Michael; Ma, Lijun et al. (2006) CHRM3 gene variation is associated with decreased acute insulin secretion and increased risk for early-onset type 2 diabetes in Pima Indians. Diabetes 55:3625-9
Nair, S; Lee, Y H; Rousseau, E et al. (2005) Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia 48:1784-8
Muller, Yunhua Li; Infante, Aniello M; Hanson, Robert L et al. (2005) Variants in hepatocyte nuclear factor 4alpha are modestly associated with type 2 diabetes in Pima Indians. Diabetes 54:3035-9
Kovacs, P; Ma, L; Hanson, R L et al. (2005) Genetic variation in UCP2 (uncoupling protein-2) is associated with energy metabolism in Pima Indians. Diabetologia 48:2292-5

Showing the most recent 10 out of 24 publications